TAMPA, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets: PGXC), a publicly traded company, pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners, retail establishments and the Internet on websites such as www.PanGenex.com, www.HeartHealthyWorld.com and www.Calgenex.com.
